Plasma/Serum cfc-DNA/cfc-RNA Advanced Fractionation Kit
For rapid and simple simultaneous purification of all sizes of cell-free circulating DNA (cfc-DNA), and circulating tumour DNA (Ct-DNA) and circulating/exosomal RNA, including microRNA from the same plasma/serum sample
For research use only and NOT intended for in vitro diagnostics.
Plasma/Serum cfc-DNA/cfc-RNA Advanced Fractionation Kit
For rapid and simple simultaneous purification of all sizes of cell-free circulating DNA (cfc-DNA), and circulating tumour DNA (Ct-DNA) and circulating/exosomal RNA, including microRNA from the same plasma/serum sample
Register today to receive an exclusive 15% off* on your first order.
Features and Benefits
- Versatile plasma/serum input ranging from 1 mL to 6 mL
- No phenol extractions or carrier RNA
- Minimal high molecular weight gDNA contamination in the purified cfc-DNA
- Bind and elute all RNA irrespective of size or GC content, without bias
- Concentrate circulating RNA and exosomal RNA into a flexible elution volume ranging from 25 µL to 50 µL
- Purify superior-quality and superior-quantity RNA in 45 minutes
- Purified RNA is suitable for a variety of downstream applications, including Small RNA Sequencing. Find out more information on Norgen's NGS services
- Purification is based on spin column chromatography that uses Norgen’s proprietary resin separation matrix
Norgen’s cfc-DNA/cfc-RNA Advanced Fractionation Kit provides fast, reliable and simple procedures for the fractionation of the highest quality and quantity of all sizes of circulating DNA and circulating RNA from various amounts of plasma/serum ranging from 1 mL up to 6 mL into two separate elutions. Purification is based on using Norgen’s proprietary resin separation matrix. The kits are designed to isolate total cfc-nucleic acid from either fresh, preserved or frozen plasma/serum samples. Moreover, these kits allow the user to elute the purified cfc-RNA and cfc-DNA into a flexible elution volume ranging from 25 µL to 50 µL. The purified plasma/serum total cfc-nucleic acid is eluted in an Elution Solution that is compatible with all downstream applications including PCR, qPCR, methylation-sensitive PCR and Southern Blot analysis, microarrays and NGS.
Details
Supporting Data
Kit Specifications
|
|
Minimum Plasma/Serum Input
|
1 mL |
Maximum Plasma/Serum Input
|
6 mL
|
Size of cfc-RNA Purified
|
All sizes, including miRNA and small RNA (< 200 nt)
|
Optimal size of purified cfc-DNA
|
146 - 180 bp
|
Elution Volume |
25-50 µL
|
Time to Complete 10 Purifications |
45 minutes
|
Average Yields* | Variable depending on specimen |
*Please check page 5 in the product manual for the Plasma/Serum Average Yields and the Common RNA Quantification Methods.
Storage Conditions and Product Stability
All solutions should be kept tightly sealed and stored at room temperature. This kit is stable for 2 years after the date of shipment. The kit contains a ready-to-use Proteinase K, which is dissolved in a specially prepared storage buffer. The buffered Proteinase K is stable for up to 2 years after the date of shipment when stored at room temperature.
Component | Cat. 68300 (50 preps) |
---|---|
Binding Buffer A | 20 mL |
Proteinase K | 6.5 mL |
Slurry E | 12.5 mL |
Lysis Buffer A | 130 mL |
Wash Solution A | 2 x 38 mL |
Elution Buffer C | 2 x 8 mL |
Elution Buffer F | 1 x 6 mL 1 x 15 mL |
Elution Solution A | 6 mL |
Micro Spin Columns | 100 |
Mini Filter Spin Columns | 50 |
Collection Tubes | 150 |
Elution Tubes (1.7 mL) | 150 |
Product Insert | 1 |
Documentation
FAQs
Spin Column
Citations
Title | EP04.01-04 Detecting KRAS Mutations in Peripheral Blood Extracellular Vesicles in Non-Small Cell Lung Cancer Using Digital Droplet PCREP04.01-04 Detecting KRAS Mutations in Peripheral Blood Extracellular Vesicles in Non-Small Cell Lung Cancer Using Digital Droplet PCR EP04.01-04 Detecting KRAS Mutations in Peripheral Blood Extracellular Vesicles in Non-Small Cell Lung Cancer Using Di |
Citation | Journal of thoracic oncology 2023. |
Authors | C.J. Zahra, K. Chee, I.A. Yang and K.M. Fong |